Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Clinical trial NCT03687242 · COMPLETED
Trial details
- NCT number
- NCT03687242
- Sponsor
- Spruce Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-06
- Primary completion
- 2019-07-08
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.